Office of the Inspector General (OIG)

The Office of the Inspector General (OIG) has developed several reports regarding human subject protection and the ethical conduct of clinical research. The following documents lists some of these reports that may provide useful information:

• Clinical Trial Web Sites: A Promising Tool to Foster Informed Consent (OEI-01-97-00198 May 2002)
• FDA Oversight of Clinical Investigators (OEI-05-99-00350 June 2000)
• Institutional Review Boards: The Emergence of Independent Boards (OEI-01-97-00192 June 1998)
• Institutional Review Boards: Their Role in Reviewing Approved Research (OEI-01-97-00190 June 1998)
• Institutional Review Boards: A Time for Reform (OEI-01-97-00193 June 1998)
• Institutional Review Boards: Promising Approaches (OEI-01-98-00191; 6/98)
• Protecting Human Research Subjects: Status of Recommendations (OEI-01-97-00197; 4/00)
• Recruiting Human Subjects: Pressures in Industry-Sponsored Clinical Research (OEI-01-97-00195 June 2000)
• Recruiting Human Subjects: Sample Guidelines for Practice (OEI-01-97-00196; 6/00)
• The Globalization of Clinical Trials: A Growing Challenge in Protecting Human Subjects (OEi-01-00-00190; 09/01)
• Recruiting Human Subjects: Pressures in Industry-Sponsored Clinical Research (OEI-01-97-00195; 6/00)

Related Information about NINDS Clinical Research
Policies and Regulatory Matters Regarding Human Subjects Research
Clinical Research General Information